FDA Approves VP-102 for Molluscum Contagiosum
The long-awaited approval for VP-102 makes this treatment the first available therapy for the pox virus-borne skin disease.
Source: hcplive.com
Stay updated with breaking news from Integrated Results. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The long-awaited approval for VP-102 makes this treatment the first available therapy for the pox virus-borne skin disease.